116 related articles for article (PubMed ID: 10561842)
1. Antisense oligonucleotides as modulators of pre-mRNA splicing.
Sierakowska H; Agrawal S; Kole R
Methods Mol Biol; 2000; 133():223-33. PubMed ID: 10561842
[No Abstract] [Full Text] [Related]
2. Antisense oligonucleotides and RNAs as modulators of pre-mRNA splicing.
Sierakowska H; Gorman L; Kang SH; Kole R
Methods Enzymol; 2000; 313():506-21. PubMed ID: 10595376
[No Abstract] [Full Text] [Related]
3. Correction of aberrant pre-mRNA splicing by antisense oligonucleotides in beta-thalassemia Egyptian patients with IVSI-110 mutation.
El-Beshlawy A; Mostafa A; Youssry I; Gabr H; Mansour IM; El-Tablawy M; Aziz M; Hussein IR
J Pediatr Hematol Oncol; 2008 Apr; 30(4):281-4. PubMed ID: 18391696
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of splice sites to antisense oligonucleotides in vivo.
Sierakowska H; Sambade MJ; Schümperli D; Kole R
RNA; 1999 Mar; 5(3):369-77. PubMed ID: 10094306
[TBL] [Abstract][Full Text] [Related]
5. Repair of thalassemic human beta-globin mRNA in mammalian cells by antisense oligonucleotides.
Sierakowska H; Sambade MJ; Agrawal S; Kole R
Proc Natl Acad Sci U S A; 1996 Nov; 93(23):12840-4. PubMed ID: 8917506
[TBL] [Abstract][Full Text] [Related]
6. Design and In Vitro Use of Antisense Oligonucleotides to Correct Pre-mRNA Splicing Defects in Inherited Retinal Dystrophies.
Garanto A; Collin RWJ
Methods Mol Biol; 2018; 1715():61-78. PubMed ID: 29188506
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of globin gene expression in different thalassaemia disorders: individual variation of β(E) pre-mRNA splicing determine disease severity.
Tubsuwan A; Munkongdee T; Jearawiriyapaisarn N; Boonchoy C; Winichagoon P; Fucharoen S; Svasti S
Br J Haematol; 2011 Sep; 154(5):635-43. PubMed ID: 21732929
[TBL] [Abstract][Full Text] [Related]
8. Restoration of human beta-globin gene expression in murine and human IVS2-654 thalassemic erythroid cells by free uptake of antisense oligonucleotides.
Suwanmanee T; Sierakowska H; Lacerra G; Svasti S; Kirby S; Walsh CE; Fucharoen S; Kole R
Mol Pharmacol; 2002 Sep; 62(3):545-53. PubMed ID: 12181431
[TBL] [Abstract][Full Text] [Related]
9. Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides.
Dominski Z; Kole R
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8673-7. PubMed ID: 8378346
[TBL] [Abstract][Full Text] [Related]
10. Surveying cis-acting sequences of pre-mRNA by adding antisense 2'-O-methyl oligoribonucleotides to a splicing reaction.
Mayeda A; Hayase Y; Inoue H; Ohtsuka E; Ohshima Y
J Biochem; 1990 Sep; 108(3):399-405. PubMed ID: 2277033
[TBL] [Abstract][Full Text] [Related]
11. Modification of pre-mRNA splicing by antisense oligonucleotides.
Kole R
Acta Biochim Pol; 1997; 44(2):231-7. PubMed ID: 9360712
[TBL] [Abstract][Full Text] [Related]
12. The essential pre-mRNA splicing factor SF2 influences 5' splice site selection by activating proximal sites.
Krainer AR; Conway GC; Kozak D
Cell; 1990 Jul; 62(1):35-42. PubMed ID: 2364434
[TBL] [Abstract][Full Text] [Related]
13. Antisense-mediated exon skipping to shift alternative splicing to treat cancer.
Wan J
Methods Mol Biol; 2012; 867():201-8. PubMed ID: 22454063
[TBL] [Abstract][Full Text] [Related]
14. Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNA.
Ittig D; Liu S; Renneberg D; Schümperli D; Leumann CJ
Nucleic Acids Res; 2004; 32(1):346-53. PubMed ID: 14726483
[TBL] [Abstract][Full Text] [Related]
15. Delivery of antisense oligonucleotides and plasmid DNA with various carrier agents.
Kang SH; Zirbes EL; Kole R
Antisense Nucleic Acid Drug Dev; 1999 Dec; 9(6):497-505. PubMed ID: 10645775
[TBL] [Abstract][Full Text] [Related]
16. A 5' splice-region G----C mutation in exon 1 of the human beta-globin gene inhibits pre-mRNA splicing: a mechanism for beta+-thalassemia.
Vidaud M; Gattoni R; Stevenin J; Vidaud D; Amselem S; Chibani J; Rosa J; Goossens M
Proc Natl Acad Sci U S A; 1989 Feb; 86(3):1041-5. PubMed ID: 2915972
[TBL] [Abstract][Full Text] [Related]
17. Antisense oligonucleotides with different backbones. Modification of splicing pathways and efficacy of uptake.
Schmajuk G; Sierakowska H; Kole R
J Biol Chem; 1999 Jul; 274(31):21783-9. PubMed ID: 10419493
[TBL] [Abstract][Full Text] [Related]
18. Effects of RNA secondary structure on alternative splicing of pre-mRNA: is folding limited to a region behind the transcribing RNA polymerase?
Eperon LP; Graham IR; Griffiths AD; Eperon IC
Cell; 1988 Jul; 54(3):393-401. PubMed ID: 2840206
[TBL] [Abstract][Full Text] [Related]
19. Restoration of hemoglobin A synthesis in erythroid cells from peripheral blood of thalassemic patients.
Lacerra G; Sierakowska H; Carestia C; Fucharoen S; Summerton J; Weller D; Kole R
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9591-6. PubMed ID: 10944225
[TBL] [Abstract][Full Text] [Related]
20. Reversal of aberrant splicing of beta-thalassemia allele by antisense RNA in vitro and in vivo.
Zeng Y; Gu X; Chen Y; Gong L; Ren Z; Huang S
Chin Med J (Engl); 1999 Feb; 112(2):107-11. PubMed ID: 11593572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
